UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 292,870 Shares of Celsius Holdings, Inc. (NASDAQ:CELH)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its stake in shares of Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) by 43.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 379,397 shares of the company's stock after selling 292,870 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.16% of Celsius worth $9,993,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of the stock. Louisiana State Employees Retirement System raised its holdings in shares of Celsius by 0.9% during the 4th quarter. Louisiana State Employees Retirement System now owns 43,700 shares of the company's stock valued at $1,151,000 after buying an additional 400 shares during the period. Blue Trust Inc. increased its holdings in Celsius by 32.8% during the 4th quarter. Blue Trust Inc. now owns 1,786 shares of the company's stock worth $47,000 after purchasing an additional 441 shares during the last quarter. TD Private Client Wealth LLC increased its holdings in shares of Celsius by 14.0% in the 4th quarter. TD Private Client Wealth LLC now owns 3,743 shares of the company's stock valued at $99,000 after acquiring an additional 459 shares during the last quarter. Treasurer of the State of North Carolina increased its holdings in shares of Celsius by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 77,438 shares of the company's stock valued at $2,040,000 after acquiring an additional 490 shares during the last quarter. Finally, Apriem Advisors increased its holdings in shares of Celsius by 3.0% in the 4th quarter. Apriem Advisors now owns 18,149 shares of the company's stock valued at $478,000 after acquiring an additional 525 shares during the last quarter. 60.95% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Joyce Russell sold 4,000 shares of the stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $28.47, for a total transaction of $113,880.00. Following the transaction, the director now owns 19,106 shares of the company's stock, valued at approximately $543,947.82. This represents a 17.31% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Paul H. Storey sold 10,188 shares of the stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $25.77, for a total value of $262,544.76. Following the transaction, the insider now directly owns 45,297 shares in the company, valued at approximately $1,167,303.69. This represents a 18.36% decrease in their position. The disclosure for this sale can be found here. Insiders own 2.55% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on CELH shares. UBS Group boosted their price target on Celsius from $43.00 to $48.00 and gave the company a "buy" rating in a report on Thursday, April 17th. JPMorgan Chase & Co. boosted their price target on Celsius from $39.00 to $44.00 and gave the company an "overweight" rating in a report on Friday, May 2nd. Piper Sandler boosted their price target on Celsius from $44.00 to $45.00 and gave the company an "overweight" rating in a report on Wednesday. Stifel Nicolaus lowered their price target on Celsius from $45.00 to $37.00 and set a "buy" rating for the company in a report on Monday, February 10th. Finally, LADENBURG THALM/SH SH lowered their price objective on Celsius from $62.00 to $58.00 and set a "neutral" rating for the company in a research note on Thursday, March 27th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and thirteen have issued a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $46.94.

Celsius Price Performance

Shares of Celsius stock traded up $0.91 during trading on Wednesday, hitting $40.09. The stock had a trading volume of 10,817,513 shares, compared to its average volume of 8,068,307. The firm has a market cap of $10.33 billion, a P/E ratio of 91.12, a PEG ratio of 2.90 and a beta of 1.65. The business has a fifty day moving average of $36.61 and a two-hundred day moving average of $30.65. Celsius Holdings, Inc. has a fifty-two week low of $21.10 and a fifty-two week high of $75.69.

Celsius (NASDAQ:CELH - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $0.18 EPS for the quarter, missing the consensus estimate of $0.20 by ($0.02). The company had revenue of $329.28 million for the quarter, compared to analysts' expectations of $349.09 million. Celsius had a net margin of 10.70% and a return on equity of 51.89%. The company's revenue for the quarter was down 7.4% on a year-over-year basis. During the same period in the prior year, the company earned $0.27 earnings per share. As a group, research analysts forecast that Celsius Holdings, Inc. will post 0.89 earnings per share for the current year.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.